Abstract
THE sequence of glucagon-like peptide-1 (7–36) amide (GLP-1) is completely conserved in all mammalian species studied, implying that it plays a critical physiological role1. We have shown that GLP-1 and its specific receptors are present in the hypo-thalamus2,3. No physiological role for central GLP-1 has been established. We report here that intracerebroventricular (ICV) GLP-1 powerfully inhibits feeding in fasted rats. ICV injection of the specific GLP-1-receptor antagonist, exendin (9-39)4, blocked the inhibitory effect of GLP-1 on food intake. Exendin (9-39) alone had no influence on fast-induced feeding but more than doubled food intake in satiated rats, and augmented the feeding response to the appetite stimulant, neuropeptide Y. Induction of c-fos is a marker of neuronal activation5. Following ICV GLP-1 injection, c-fos appeared exclusively in the paraventricular nucleus of the hypothalamus and central nucleus of the amygdala, and this was inhibited by prior administration of exendin (9-39). Both of these regions of the brain are of primary importance in the regulation of feeding6. These findings suggest that central GLP-1 is a new physiological mediator of satiety.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
204,58 €
only 4,01 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Orskov, C. Diabetologia 35, 701–711 (1992).
Kreymann, B. et al. Brain Res. 502, 325–331 (1989).
Kanse, S. M., Kreymann, B., Ghatei, M. A. & Bloom, S. R. FEBS Lett. 241, 209–212 (1988).
Goke, R. et al. J. biol. Chem. 268, 19650–19655 (1993).
Sagar, S. M., Sharp, F. R. & Curran, T. Science 240, 1328–1331 (1988).
Morley, J. E. Endocr. Rev. 8, 256–287 (1987).
Antin, J., Gibbs, J., Holt, J., Young, R. C. & Smith, G. P. J. comp. Physiol. Psychol. 89, 784–790 (1975).
Chow, H. L. & Beck, C. H. Eur. J. Pharmac. 102, 297–304 (1984).
Wilding, J. P. et al. J. Endocr. 132, 299–304 (1992).
Blundell, J. E., Rogers, P. J. & Hill, A. J. Brain Res. Bull. 15, 371–376 (1985).
Suzuki, S., Kawai, K., Ohashi, S., Mukai, H. & Yamashita, K. Endocrinology 125, 3109–3114 (1989).
Rai, A., Singh, G., Raffaniello, R., Eng, J. & Raufman, J. P. Am. J. Physiol 265, G118–125 (1993).
Wang, Z. et al. J. clin. Invest. 95, 417–421 (1995).
Kulkarni, R. N. et al. Reg. Pept. 57, 201 (1995).
Billington, C. J., Levine, A. S. & Morley, J. E. Am. J. Physiol. 245, R920–926 (1983).
Clark, J. T., Kalra, P. S. & Kalra, S. P. Endocrinology 117, 2435–2442 (1985).
Lambert, P. D. et al. Endocrinology 133, 29–32 (1993).
Wilding, J. P., Gilbey, S. G., Lambert, P. D., Ghatei, M. A. & Bloom, S. R. Neuroendocrinology. 57, 581–587 (1993).
Pelleymounter, M. A. et al. Science 269, 540–543 (1995).
Halaas, J. L. et al. Science 269, 543–546 (1995).
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R. & Burn, P. Science 269, 546–549 (1995).
Veale, P. R., Bhogal, R., Morgan, D. G., Smith, D. M. & Bloom, S. R. Eur. J. Pharmac. 262, 133–141 (1994).
Lambert, P. D., Phillips, P. J., Wilding, J. P. H., Bloom, S. R. & Herbert, J. Brain Res. 670, 59–65 (1995).
Arnold, F. J. et al. Neuroscience 51, 377–390 (1992).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Turton, M., O'Shea, D., Gunn, I. et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69–72 (1996). https://doi.org/10.1038/379069a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/379069a0
Further reading
-
Role and mechanism(s) of incretin-dependent therapies for treating diabetes mellitus
Environmental Science and Pollution Research (2022)
-
Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study
European Journal of Clinical Pharmacology (2022)
-
Advances in GLP-1 treatment: focus on oral semaglutide
Diabetology & Metabolic Syndrome (2021)
-
Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial
Cardiovascular Diabetology (2021)
-
Six-month changes in ghrelin and glucagon-like peptide-1 with weight loss are unrelated to long-term weight regain in obese older adults
International Journal of Obesity (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.